Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Enhertu approved in the US as the first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
-
Acquisition of TeneoTwo for its clinical-stage T-cell engager completed
-
Datopotamab deruxtecan-based combinations show promising clinical activity in patients with advanced non-small cell lung cancer
-
Tagrisso plus savolitinib demonstrated 49% objective response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial
-
Enhertu approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
-
Calquence tablet formulation approved in the US across current indications
-
Lynparza approved in the EU as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
-
Michel Demaré to succeed Leif Johansson as Non-Executive Chair of the Board
-
H1 2022 results
-
Tezspire recommended for approval in the EU by CHMP for the treatment of severe asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
